Related Experiment Video
Updated: Aug 15, 2026
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective
1Department of Neurology, Division of Neuroimmunology, Wayne State University School of Medicine, Detroit, MI 48201, USA. skundric@cmb.biosci.wayne.edu
Abstract:
Multiple sclerosis (MS) and its model experimental autoimmune encephalomyelitis (EAE) are debilitating paralytic diseases caused by inflammation, demyelination and axonal degeneration of the central nervous system (CNS). Whilst the autoimmune nature of MS is strongly suggested by evidence of myelin specific autoreactive T cells and antibodies, EAE is an experimentally induced CNS specific autoimmune disease. As opposed to the majority of MS patients, which exhibit a relapsing-remitting course of the disease, only a handful of available EAE models displays relapsing-remitting course. In this review, we will summarize differences in regulation of acute and relapsing disease with emphasis on relapsing-remitting EAE models, and outline advantages and limitations of available relapsing EAE models pertinent for studies of relapsing human disease. We will discuss current concepts of relapse regulation by focusing on immune and molecular mechanisms of neuroinflammation, oligodendrocyte damage, myelin loss and axonal degeneration. This review will compare our present understanding of relapse regulation in human versus experimental autoimmune disease. Translation of mechanisms learned from relapsing EAE into development of new therapies for MS will be evaluated. Finally, perspectives in further optimization and development of more suitable experimental models to study human relapsing-remitting MS will be discussed.
Insights
This review compares relapsing-remitting experimental autoimmune encephalomyelitis (EAE) models to human multiple sclerosis (MS), focusing on disease regulation mechanisms. It evaluates EAE models for studying MS and developing new therapies.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) are CNS diseases involving inflammation, demyelination, and axonal degeneration.
- While MS is autoimmune, EAE is experimentally induced; most MS patients have relapsing-remitting disease, unlike typical EAE models.
Purpose of the Study:
- To summarize differences in acute vs. relapsing disease regulation, emphasizing relapsing-remitting EAE models.
- To outline the advantages and limitations of EAE models for studying human relapsing MS.
- To evaluate the translation of EAE findings into MS therapies.
Main Methods:
- Review of current literature on EAE and MS.
- Focus on immune and molecular mechanisms of neuroinflammation, oligodendrocyte damage, myelin loss, and axonal degeneration.
- Comparison of relapse regulation in human MS and experimental autoimmune disease.
Main Results:
- Few EAE models accurately replicate the relapsing-remitting course seen in most MS patients.
- Understanding relapse regulation involves complex immune and molecular pathways affecting the CNS.
- Current EAE models offer insights but have limitations for studying human MS.
Conclusions:
- Relapsing-remitting EAE models are crucial for understanding MS pathogenesis and developing targeted therapies.
- Further optimization of EAE models is needed to better mimic human relapsing-remitting MS.
- Translating findings from EAE to MS therapies requires careful consideration of model-specific mechanisms.
More Related Videos
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
05:44Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
